Biotech Values

[iwfal]

Ozempic and NAION risk:

How does that thesis gibe with the study’s findings in the non-T2D study group?

Don't know, but not willing to pay for paper and given the quality of error here… i’d be surprised if the non-T2D wasnt similarly bad in some way. I say that for two reasons:

A) the asserted NAION rate is really high. So high it would have shown up in the RCTs of which there were many and they are huge. This is much more severe than the comparatively small surprise HbA1c jump in statin trials.

B) the quality of the error in T2D implies some motivated overlooking of issues. For whatever reason people get oddly religious on both sides of the Ozempic debate.

And a restatement: my guess is its real, but much smaller than presented. My guess as to why it happens: speed of weight loss, poor nutrition (nutrition related neuropathy after bariatric surgery is a thing https://onlinelibrary.wiley.com/doi/pdf/10.1155/2012/608534)